Johan Lundberg
Professor/Senior Physician, Psychiatry
Data updated
Research Footprint
Johan Lundberg appears in 6 tracked papers (2022–2026), most studied alongside Psilocybin, Placebo and Ketamine, across Depressive Disorders, Anxiety Disorders and Palliative & End-of-Life Distress.
Most-cited paper: International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators (78 citations).
Frequent co-authors: Dea Stenbæk, Suresh Muthukumaraswamy and Sanjay Mathew.
Background & Research
Johan Lundberg is a professor and senior physician in psychiatry at Karolinska Institutet. His research group focuses on molecular brain imaging, neuropsychopharmacology, depression, and anxiety disorders. He appears as a coauthor on studies spanning psilocybin-assisted depression treatment, ketamine response, and broader psychiatric outcomes.
Key Impact
He is a recurring coauthor on multiple psychedelic and depression trials, including psilocybin and ketamine studies, and is affiliated with a major psychiatric research group at Karolinska Institutet.
Collaboration Network
19 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Johan Lundberg's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.